 GreenBank Capital CSE:GBC Inc said it has mutually agreed to terminate a commercial agreement with Pharmakure Limited, that would have seen it acquiring a shareholding in the biotech company and provide it with merchant banking services, and the two are currently discussing new terms. The companies have agreed that there are no further accrued rights, entitlements, obligations, or funding requirements under the November 2020 agreement by either party and that all costs incurred to date by either company are for their own account, it added. 